x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Ohio
|
|
34-0183970
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification Number)
|
|
|
|
5995 Mayfair Road, PO Box 3077, North Canton, Ohio
|
|
44720-8077
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Large accelerated filer
|
x
|
Accelerated filer
|
o
|
Non-accelerated filer
(Do not check if a smaller reporting company)
|
o
|
Smaller reporting company
|
o
|
PART I –
FINANCIAL INFORMATION
|
|
ITEM 1:
FINANCIAL STATEMENTS
|
|
ITEM 4:
CONTROLS AND PROCEDURES
|
|
PART II –
OTHER INFORMATION
|
|
ITEM 1:
LEGAL PROCEEDINGS
|
|
ITEM 1A:
RISK FACTORS
|
|
ITEM 3:
DEFAULTS UPON SENIOR SECURITIES
|
|
ITEM 4:
MINE SAFETY DISCLOSURES
|
|
ITEM 5:
OTHER INFORMATION
|
|
ITEM 6:
EXHIBITS
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
|
|
(Unaudited)
|
|
|
||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
311,437
|
|
|
$
|
333,920
|
|
Short-term investments
|
|
300,051
|
|
|
286,853
|
|
||
Trade receivables, less allowances for doubtful accounts of $23,027 and $22,128, respectively
|
|
447,949
|
|
|
414,969
|
|
||
Inventories
|
|
493,831
|
|
|
440,900
|
|
||
Deferred income taxes
|
|
112,824
|
|
|
114,250
|
|
||
Prepaid expenses
|
|
34,860
|
|
|
31,452
|
|
||
Other current assets
|
|
134,945
|
|
|
110,011
|
|
||
Total current assets
|
|
1,835,897
|
|
|
1,732,355
|
|
||
Securities and other investments
|
|
74,876
|
|
|
74,869
|
|
||
Property, plant and equipment, at cost
|
|
652,695
|
|
|
642,256
|
|
||
Less accumulated depreciation and amortization
|
|
460,184
|
|
|
449,562
|
|
||
Property, plant and equipment, net
|
|
192,511
|
|
|
192,694
|
|
||
Goodwill
|
|
257,374
|
|
|
253,063
|
|
||
Deferred income taxes
|
|
91,752
|
|
|
91,090
|
|
||
Other assets
|
|
178,982
|
|
|
173,372
|
|
||
Total assets
|
|
$
|
2,631,392
|
|
|
$
|
2,517,443
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Notes payable
|
|
$
|
39,425
|
|
|
$
|
21,722
|
|
Accounts payable
|
|
231,478
|
|
|
221,964
|
|
||
Deferred revenue
|
|
287,360
|
|
|
241,992
|
|
||
Payroll and other benefits liabilities
|
|
55,992
|
|
|
79,854
|
|
||
Other current liabilities
|
|
253,068
|
|
|
258,685
|
|
||
Total current liabilities
|
|
867,323
|
|
|
824,217
|
|
||
Long-term debt
|
|
618,095
|
|
|
606,154
|
|
||
Pensions and other benefits
|
|
136,210
|
|
|
148,399
|
|
||
Postretirement and other benefits
|
|
23,547
|
|
|
23,196
|
|
||
Deferred income taxes
|
|
32,914
|
|
|
32,029
|
|
||
Other long-term liabilities
|
|
28,300
|
|
|
25,188
|
|
||
Commitments and contingencies
|
|
—
|
|
|
—
|
|
||
Equity
|
|
|
|
|
||||
Diebold, Incorporated shareholders' equity
|
|
|
|
|
||||
Preferred shares, no par value, 1,000,000 authorized shares, none issued
|
|
—
|
|
|
—
|
|
||
Common shares, $1.25 par value, 125,000,000 authorized shares, 77,389,520 and 76,840,956 issued shares, 62,986,756 and 62,513,615 outstanding shares, respectively
|
|
96,737
|
|
|
96,051
|
|
||
Additional capital
|
|
340,818
|
|
|
327,805
|
|
||
Retained earnings
|
|
1,018,279
|
|
|
991,210
|
|
||
Treasury shares, at cost (14,402,764 and 14,327,341 shares, respectively)
|
|
(550,622
|
)
|
|
(547,737
|
)
|
||
Accumulated other comprehensive income
|
|
(11,165
|
)
|
|
(40,343
|
)
|
||
Total Diebold, Incorporated shareholders' equity
|
|
894,047
|
|
|
826,986
|
|
||
Noncontrolling interests
|
|
30,956
|
|
|
31,274
|
|
||
Total equity
|
|
925,003
|
|
|
858,260
|
|
||
Total liabilities and equity
|
|
$
|
2,631,392
|
|
|
$
|
2,517,443
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2012
|
|
2011
|
||||
Net sales
|
|
|
|
|
||||
Services
|
|
$
|
396,865
|
|
|
$
|
364,374
|
|
Products
|
|
301,626
|
|
|
249,783
|
|
||
|
|
698,491
|
|
|
614,157
|
|
||
Cost of sales
|
|
|
|
|
||||
Services
|
|
285,396
|
|
|
275,890
|
|
||
Products
|
|
219,855
|
|
|
188,863
|
|
||
|
|
505,251
|
|
|
464,753
|
|
||
Gross profit
|
|
193,240
|
|
|
149,404
|
|
||
Selling and administrative expense
|
|
119,795
|
|
|
121,111
|
|
||
Research, development and engineering expense
|
|
18,801
|
|
|
19,424
|
|
||
|
|
138,596
|
|
|
140,535
|
|
||
Operating profit
|
|
54,644
|
|
|
8,869
|
|
||
Other income (expense)
|
|
|
|
|
||||
Investment income
|
|
11,955
|
|
|
10,898
|
|
||
Interest expense
|
|
(7,608
|
)
|
|
(8,673
|
)
|
||
Foreign exchange gain (loss), net
|
|
545
|
|
|
(1,046
|
)
|
||
Miscellaneous, net
|
|
(90
|
)
|
|
23
|
|
||
Income from continuing operations before taxes
|
|
59,446
|
|
|
10,071
|
|
||
Taxes on income
|
|
13,481
|
|
|
5,925
|
|
||
Income from continuing operations
|
|
45,965
|
|
|
4,146
|
|
||
Loss from discontinued operations, net of tax
|
|
—
|
|
|
(11
|
)
|
||
Net income
|
|
45,965
|
|
|
4,135
|
|
||
Net income attributable to noncontrolling interests
|
|
802
|
|
|
1,634
|
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
45,163
|
|
|
$
|
2,501
|
|
|
|
|
|
|
||||
Basic weighted-average shares outstanding
|
|
62,725
|
|
|
65,762
|
|
||
Diluted weighted-average shares outstanding
|
|
63,333
|
|
|
66,230
|
|
||
|
|
|
|
|
||||
Basic earnings per share
|
|
|
|
|
||||
Income from continuing operations, net of tax
|
|
$
|
0.72
|
|
|
$
|
0.04
|
|
Loss from discontinued operations, net of tax
|
|
—
|
|
|
—
|
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
0.72
|
|
|
$
|
0.04
|
|
|
|
|
|
|
||||
Diluted earnings per share
|
|
|
|
|
||||
Income from continuing operations, net of tax
|
|
$
|
0.71
|
|
|
$
|
0.04
|
|
Loss from discontinued operations, net of tax
|
|
—
|
|
|
—
|
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
0.71
|
|
|
$
|
0.04
|
|
|
|
|
|
|
||||
Amounts attributable to Diebold, Incorporated
|
|
|
|
|
||||
Income from continuing operations, net of tax
|
|
$
|
45,163
|
|
|
$
|
2,512
|
|
Loss from discontinued operations, net of tax
|
|
—
|
|
|
(11
|
)
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
45,163
|
|
|
$
|
2,501
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2012
|
|
2011
|
||||
Net income
|
|
$
|
45,965
|
|
|
$
|
4,135
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
||
Foreign currency hedges and translation
|
|
25,565
|
|
|
14,945
|
|
||
Interest rate hedges:
|
|
|
|
|
|
|
||
Gain recognized in other comprehensive income
|
|
170
|
|
|
40
|
|
||
Less: reclassification adjustment for gains included in net income
|
|
94
|
|
|
89
|
|
||
|
|
76
|
|
|
(49
|
)
|
||
Pension and other postretirement benefits:
|
|
|
|
|
||||
Net actuarial loss amortization
|
|
4,332
|
|
|
2,503
|
|
||
Net prior service cost (benefit) amortization
|
|
(64
|
)
|
|
(64
|
)
|
||
Other
|
|
5
|
|
|
(1,710
|
)
|
||
|
|
4,273
|
|
|
729
|
|
||
Unrealized gain (loss), net on securities:
|
|
|
|
|
||||
Unrealized holding losses arising during period
|
|
(416
|
)
|
|
(837
|
)
|
||
Less: reclassification adjustment for gains (losses) included in net income
|
|
328
|
|
|
(164
|
)
|
||
|
|
(744
|
)
|
|
(673
|
)
|
||
Other comprehensive income, net of tax
|
|
29,170
|
|
|
14,952
|
|
||
Comprehensive income
|
|
75,135
|
|
|
19,087
|
|
||
Less: comprehensive income attributable to noncontrolling interests
|
|
794
|
|
|
1,905
|
|
||
Comprehensive income attributable to Diebold, Incorporated
|
|
$
|
74,341
|
|
|
$
|
17,182
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2012
|
|
2011
|
||||
Cash flow from operating activities:
|
|
|
|
|
||||
Net income
|
|
$
|
45,965
|
|
|
$
|
4,135
|
|
Adjustments to reconcile net income to cash flow from operating activities:
|
|
|
|
|
||||
Depreciation and amortization
|
|
19,711
|
|
|
19,246
|
|
||
Share-based compensation
|
|
3,797
|
|
|
3,435
|
|
||
Excess tax benefits from share-based compensation
|
|
(1,269
|
)
|
|
(1,484
|
)
|
||
Equity in earnings of an investee
|
|
(247
|
)
|
|
(425
|
)
|
||
Cash flow from changes in certain assets and liabilities:
|
|
|
|
|
||||
Trade receivables
|
|
(26,535
|
)
|
|
(8,072
|
)
|
||
Inventories
|
|
(45,268
|
)
|
|
(21,955
|
)
|
||
Prepaid expenses
|
|
(3,045
|
)
|
|
158
|
|
||
Other current assets
|
|
(24,992
|
)
|
|
(15,419
|
)
|
||
Accounts payable
|
|
7,063
|
|
|
(29,404
|
)
|
||
Deferred revenue
|
|
42,378
|
|
|
25,078
|
|
||
Certain other assets and liabilities
|
|
(43,579
|
)
|
|
(65,444
|
)
|
||
Net cash used in operating activities
|
|
(26,021
|
)
|
|
(90,151
|
)
|
||
Cash flow from investing activities:
|
|
|
|
|
||||
Proceeds from maturities of investments
|
|
88,698
|
|
|
59,292
|
|
||
Proceeds from sale of investments
|
|
5,808
|
|
|
7,117
|
|
||
Payments for purchases of investments
|
|
(99,738
|
)
|
|
(56,720
|
)
|
||
Proceeds from sale of assets
|
|
—
|
|
|
175
|
|
||
Capital expenditures
|
|
(12,297
|
)
|
|
(10,902
|
)
|
||
Collections on purchased finance receivables
|
|
4,438
|
|
|
7,338
|
|
||
Increase in certain other assets
|
|
(6,692
|
)
|
|
(4,103
|
)
|
||
Net cash (used in) provided by investing activities
|
|
(19,783
|
)
|
|
2,197
|
|
||
Cash flow from financing activities:
|
|
|
|
|
||||
Dividends paid
|
|
(18,094
|
)
|
|
(18,650
|
)
|
||
Debt borrowings
|
|
263,724
|
|
|
156,637
|
|
||
Debt repayments
|
|
(234,264
|
)
|
|
(85,210
|
)
|
||
Issuance of common shares
|
|
9,902
|
|
|
4,017
|
|
||
Repurchase of common shares
|
|
(2,885
|
)
|
|
(21,451
|
)
|
||
Other
|
|
157
|
|
|
615
|
|
||
Net cash provided by financing activities
|
|
18,540
|
|
|
35,958
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
|
4,781
|
|
|
2,900
|
|
||
Decrease in cash and cash equivalents
|
|
(22,483
|
)
|
|
(49,096
|
)
|
||
Cash and cash equivalents at the beginning of the period
|
|
333,920
|
|
|
328,658
|
|
||
Cash and cash equivalents at the end of the period
|
|
$
|
311,437
|
|
|
$
|
279,562
|
|
|
|
2012
|
|
2011
|
||||
Numerator:
|
|
|
|
|
||||
Income used in basic and diluted earnings per share:
|
|
|
|
|
||||
Income from continuing operations, net of tax
|
|
$
|
45,163
|
|
|
$
|
2,512
|
|
Loss from discontinued operations, net of tax
|
|
—
|
|
|
(11
|
)
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
45,163
|
|
|
$
|
2,501
|
|
Denominator (in thousands):
|
|
|
|
|
||||
Weighted-average number of common shares used in basic earnings per share
|
|
62,725
|
|
|
65,762
|
|
||
Effect of dilutive shares
|
|
608
|
|
|
468
|
|
||
Weighted-average number of shares used in diluted earnings per share
|
|
63,333
|
|
|
66,230
|
|
||
Basic earnings per share:
|
|
|
|
|
||||
Net income from continuing operations
|
|
$
|
0.72
|
|
|
$
|
0.04
|
|
Loss from discontinued operations
|
|
—
|
|
|
—
|
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
0.72
|
|
|
$
|
0.04
|
|
Diluted earnings per share:
|
|
|
|
|
||||
Net income from continuing operations
|
|
$
|
0.71
|
|
|
$
|
0.04
|
|
Loss from discontinued operations
|
|
—
|
|
|
—
|
|
||
Net income attributable to Diebold, Incorporated
|
|
$
|
0.71
|
|
|
$
|
0.04
|
|
Anti-dilutive shares (in thousands):
|
|
|
|
|
||||
Anti-dilutive shares not used in calculating diluted weighted-average shares
|
|
1,596
|
|
|
2,023
|
|
|
2012
|
|
2011
|
||||
Diebold, Incorporated shareholders' equity
|
|
|
|
||||
Balance at beginning of period
|
$
|
826,986
|
|
|
$
|
961,155
|
|
Comprehensive income attributable to Diebold, Incorporated
|
74,341
|
|
|
17,182
|
|
||
Common shares
|
686
|
|
|
537
|
|
||
Additional capital
|
13,013
|
|
|
8,257
|
|
||
Treasury shares
|
(2,885
|
)
|
|
(21,451
|
)
|
||
Dividends declared
|
(18,094
|
)
|
|
(18,650
|
)
|
||
Balance at end of period
|
$
|
894,047
|
|
|
$
|
947,030
|
|
|
|
|
|
||||
Noncontrolling interests
|
|
|
|
||||
Balance at beginning of period
|
$
|
31,274
|
|
|
$
|
28,659
|
|
Comprehensive income attributable to noncontrolling interests
|
794
|
|
|
1,905
|
|
||
Distributions to noncontrolling interest holders
|
(1,112
|
)
|
|
(310
|
)
|
||
Balance at end of period
|
$
|
30,956
|
|
|
$
|
30,254
|
|
|
|
Number of
Shares
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value (1)
|
|||||
|
|
(in thousands)
|
|
(per share)
|
|
(in years)
|
|
|
|||||
Outstanding at January 1, 2012
|
|
3,201
|
|
|
$
|
36.70
|
|
|
|
|
|
||
Expired or forfeited
|
|
(400
|
)
|
|
$
|
36.70
|
|
|
|
|
|
||
Exercised
|
|
(331
|
)
|
|
$
|
29.93
|
|
|
|
|
|
||
Granted
|
|
539
|
|
|
$
|
34.89
|
|
|
|
|
|
||
Outstanding at March 31, 2012
|
|
3,009
|
|
|
$
|
37.12
|
|
|
6
|
|
$
|
13,856
|
|
Options exercisable at March 31, 2012
|
|
1,910
|
|
|
$
|
39.76
|
|
|
4
|
|
$
|
7,265
|
|
Options vested and expected to vest (2) at March 31, 2012
|
|
2,982
|
|
|
$
|
37.16
|
|
|
6
|
|
$
|
13,697
|
|
(1)
|
The aggregate intrinsic value (the difference between the closing price of the Company’s common shares on the last trading day of the first quarter of 2012 and the exercise price, multiplied by the number of “in-the-money” options) that would have been received by the option holders had all option holders exercised their options on
March 31, 2012
. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common shares.
|
(2)
|
The options expected to vest are the result of applying the pre-vesting forfeiture rate assumption to total outstanding non-vested options.
|
|
|
Number of
Shares
|
|
Weighted-Average
Grant-Date Fair
Value
|
|||
|
|
(in thousands)
|
|
|
|||
RSUs:
|
|
|
|
|
|||
Non-Vested at January 1, 2012
|
|
717
|
|
|
$
|
30.69
|
|
Forfeited
|
|
(29
|
)
|
|
$
|
29.65
|
|
Vested
|
|
(130
|
)
|
|
$
|
24.91
|
|
Granted
|
|
209
|
|
|
$
|
34.97
|
|
Non-Vested at March 31, 2012
|
|
767
|
|
|
$
|
32.88
|
|
Performance Shares (1):
|
|
|
|
|
|||
Non-Vested at January 1, 2012
|
|
727
|
|
|
$
|
34.70
|
|
Forfeited
|
|
(207
|
)
|
|
$
|
30.55
|
|
Vested
|
|
(86
|
)
|
|
$
|
29.25
|
|
Granted
|
|
285
|
|
|
$
|
44.25
|
|
Non-Vested at March 31, 2012
|
|
719
|
|
|
$
|
40.33
|
|
Director Deferred Shares:
|
|
|
|
|
|||
Non-Vested at March 31, 2012
|
|
19
|
|
|
$
|
33.98
|
|
Vested at March 31, 2012
|
|
96
|
|
|
$
|
33.88
|
|
Outstanding at March 31, 2012
|
|
115
|
|
|
$
|
33.90
|
|
(1)
|
Non-vested performance shares are based on a maximum potential payout. Actual shares granted at the end of the performance period may be less than the maximum potential payout level depending on achievement of performance share objectives.
|
|
|
Cost Basis
|
|
Unrealized
Gain (Loss)
|
|
Fair Value
|
||||||
As of March 31, 2012
|
|
|
|
|
|
|
||||||
Short-term investments:
|
|
|
|
|
|
|
||||||
Certificates of deposit
|
|
$
|
264,896
|
|
|
$
|
—
|
|
|
$
|
264,896
|
|
U.S. dollar indexed bond funds
|
|
34,561
|
|
|
594
|
|
|
35,155
|
|
|||
|
|
$
|
299,457
|
|
|
$
|
594
|
|
|
$
|
300,051
|
|
Long-term investments:
|
|
|
|
|
|
|
||||||
Assets held in a rabbi trust
|
|
$
|
7,302
|
|
|
$
|
506
|
|
|
$
|
7,808
|
|
As of December 31, 2011
|
|
|
|
|
|
|
||||||
Short-term investments:
|
|
|
|
|
|
|
||||||
Certificates of deposit
|
|
$
|
269,033
|
|
|
$
|
—
|
|
|
$
|
269,033
|
|
U.S. dollar indexed bond funds
|
|
16,482
|
|
|
1,338
|
|
|
17,820
|
|
|||
|
|
$
|
285,515
|
|
|
$
|
1,338
|
|
|
$
|
286,853
|
|
Long-term investments:
|
|
|
|
|
|
|
||||||
Assets held in a rabbi trust
|
|
$
|
7,428
|
|
|
$
|
(258
|
)
|
|
$
|
7,170
|
|
|
|
Finance
Leases
|
|
Notes
Receivable
|
|
Total
|
||||||
Allowance for credit losses
|
|
|
|
|
|
|
||||||
Balance at January 1, 2012
|
|
$
|
210
|
|
|
$
|
2,047
|
|
|
$
|
2,257
|
|
Provision for credit losses
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Recoveries
|
|
15
|
|
|
—
|
|
|
15
|
|
|||
Write-offs
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Balance at March 31, 2012
|
|
$
|
225
|
|
|
$
|
2,047
|
|
|
$
|
2,272
|
|
|
|
|
|
|
|
|
||||||
Allowance resulting from individual impairment evaluation
|
|
$
|
225
|
|
|
$
|
2,047
|
|
|
$
|
2,272
|
|
Allowance resulting from collective impairment evaluation
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
|
||||||
Financing receivables individually evaluated for impairment
|
|
$
|
100,819
|
|
|
$
|
14,134
|
|
|
$
|
114,953
|
|
Financing receivables collectively evaluated for impairment
|
|
—
|
|
|
—
|
|
|
—
|
|
30-59 days past due
|
$
|
—
|
|
60-89 days past due
|
—
|
|
|
> 89 days past due
|
1,564
|
|
|
Total past due
|
$
|
1,564
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
Finished goods
|
|
$
|
217,108
|
|
|
$
|
188,571
|
|
Service parts
|
|
159,442
|
|
|
152,597
|
|
||
Raw materials and work in process
|
|
117,281
|
|
|
99,732
|
|
||
Total inventories
|
|
$
|
493,831
|
|
|
$
|
440,900
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
Notes payable:
|
|
|
|
|
||||
Uncommitted lines of credit
|
|
$
|
39,281
|
|
|
$
|
21,572
|
|
Other
|
|
144
|
|
|
150
|
|
||
|
|
$
|
39,425
|
|
|
$
|
21,722
|
|
Long-term debt:
|
|
|
|
|
||||
Credit facility
|
|
$
|
303,000
|
|
|
$
|
291,000
|
|
Senior notes
|
|
300,000
|
|
|
300,000
|
|
||
Industrial development revenue bonds
|
|
11,900
|
|
|
11,900
|
|
||
Other
|
|
3,195
|
|
|
3,254
|
|
||
|
|
$
|
618,095
|
|
|
$
|
606,154
|
|
|
|
Pension Benefits
|
|
Other Benefits
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
||||||||
Service cost
|
|
$
|
2,862
|
|
|
$
|
2,713
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest cost
|
|
7,958
|
|
|
7,872
|
|
|
204
|
|
|
233
|
|
||||
Expected return on plan assets
|
|
(10,205
|
)
|
|
(10,183
|
)
|
|
—
|
|
|
—
|
|
||||
Amortization of prior service cost
|
|
65
|
|
|
65
|
|
|
(129
|
)
|
|
(129
|
)
|
||||
Recognized net actuarial loss
|
|
4,211
|
|
|
2,406
|
|
|
121
|
|
|
97
|
|
||||
Net periodic pension benefit cost
|
|
$
|
4,891
|
|
|
$
|
2,873
|
|
|
$
|
196
|
|
|
$
|
201
|
|
|
|
2012
|
|
2011
|
||||
Balance at January 1
|
|
$
|
63,355
|
|
|
$
|
78,313
|
|
Current period accruals (a)
|
|
15,934
|
|
|
18,411
|
|
||
Current period settlements
|
|
(14,608
|
)
|
|
(19,252
|
)
|
||
Balance at March 31
|
|
$
|
64,681
|
|
|
$
|
77,472
|
|
(a)
|
includes the impact of foreign exchange rate fluctuations
|
Income Statement Location
|
|
2012
|
|
2011
|
||||
Interest expense
|
|
$
|
(1,391
|
)
|
|
$
|
(1,849
|
)
|
Foreign exchange gain (loss), net
|
|
(2,434
|
)
|
|
(6,217
|
)
|
||
|
|
$
|
(3,825
|
)
|
|
$
|
(8,066
|
)
|
|
|
2012
|
|
2011
|
||||
Cost of sales – services
|
|
$
|
(669
|
)
|
|
$
|
6,074
|
|
Cost of sales – products
|
|
5
|
|
|
123
|
|
||
Selling and administrative expense
|
|
2,387
|
|
|
5,604
|
|
||
Total
|
|
$
|
1,723
|
|
|
$
|
11,801
|
|
|
|
2012
|
|
2011
|
||||
DNA
|
|
|
|
|
||||
Severance
|
|
$
|
1,107
|
|
|
$
|
(7
|
)
|
DI
|
|
|
|
|
||||
Severance
|
|
128
|
|
|
11,605
|
|
||
Other (1)
|
|
488
|
|
|
203
|
|
||
Total
|
|
$
|
1,723
|
|
|
$
|
11,801
|
|
(1)
|
Other costs in the DI segment include legal fees, accelerated depreciation and lease termination fees.
|
|
|
EMEA
Reorganization
|
|
Global Shared Services
|
||||
Costs incurred to date:
|
|
|
|
|
||||
DNA
|
|
$
|
—
|
|
|
$
|
1,437
|
|
DI
|
|
19,780
|
|
|
286
|
|
||
Total costs incurred to date
|
|
$
|
19,780
|
|
|
$
|
1,723
|
|
Balance at January 1, 2012
|
|
$
|
10,136
|
|
Liabilities incurred
|
|
1,723
|
|
|
Liabilities paid
|
|
(1,945
|
)
|
|
Balance at March 31, 2012
|
|
$
|
9,914
|
|
|
|
March 31, 2012
|
|
December 31, 2011
|
||||||||||||||||||||
|
|
|
|
Fair Value Measurements Using
|
|
|
|
Fair Value Measurements Using
|
||||||||||||||||
|
|
Fair Value
|
|
Level 1
|
|
Level 2
|
|
Fair Value
|
|
Level 1
|
|
Level 2
|
||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Certificates of deposit
|
|
$
|
264,896
|
|
|
$
|
264,896
|
|
|
$
|
—
|
|
|
$
|
269,033
|
|
|
$
|
269,033
|
|
|
$
|
—
|
|
U.S. dollar indexed bond funds
|
|
35,155
|
|
|
—
|
|
|
35,155
|
|
|
17,820
|
|
|
—
|
|
|
17,820
|
|
||||||
Assets held in a rabbi trust
|
|
7,808
|
|
|
7,808
|
|
|
—
|
|
|
7,170
|
|
|
7,170
|
|
|
—
|
|
||||||
Foreign exchange forward contracts
|
|
1,156
|
|
|
—
|
|
|
1,156
|
|
|
2,193
|
|
|
—
|
|
|
2,193
|
|
||||||
Total
|
|
$
|
309,015
|
|
|
$
|
272,704
|
|
|
$
|
36,311
|
|
|
$
|
296,216
|
|
|
$
|
276,203
|
|
|
$
|
20,013
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Deferred compensation
|
|
$
|
7,808
|
|
|
$
|
7,808
|
|
|
$
|
—
|
|
|
$
|
7,170
|
|
|
$
|
7,170
|
|
|
$
|
—
|
|
Foreign exchange forward contracts
|
|
582
|
|
|
—
|
|
|
582
|
|
|
1,983
|
|
|
—
|
|
|
1,983
|
|
||||||
Interest rate swaps
|
|
3,631
|
|
|
—
|
|
|
3,631
|
|
|
3,796
|
|
|
—
|
|
|
3,796
|
|
||||||
Total
|
|
$
|
12,021
|
|
|
$
|
7,808
|
|
|
$
|
4,213
|
|
|
$
|
12,949
|
|
|
$
|
7,170
|
|
|
$
|
5,779
|
|
|
|
March 31, 2012
|
|
December 31, 2011
|
||||||||||||
|
|
Fair Value
|
|
Carrying
Value
|
|
Fair Value
|
|
Carrying
Value
|
||||||||
Notes payable
|
|
$
|
39,425
|
|
|
$
|
39,425
|
|
|
$
|
21,722
|
|
|
$
|
21,722
|
|
Long-term debt
|
|
628,538
|
|
|
618,095
|
|
|
612,551
|
|
|
606,154
|
|
||||
Total debt instruments
|
|
$
|
667,963
|
|
|
$
|
657,520
|
|
|
$
|
634,273
|
|
|
$
|
627,876
|
|
|
|
2012
|
|
2011
|
||||
DNA
|
|
|
|
|
||||
Customer revenues
|
|
$
|
399,920
|
|
|
$
|
305,964
|
|
Intersegment revenues
|
|
13,607
|
|
|
19,626
|
|
||
Operating profit
|
|
55,297
|
|
|
16,152
|
|
||
Capital expenditures
|
|
5,285
|
|
|
5,779
|
|
||
Depreciation
|
|
6,895
|
|
|
6,759
|
|
||
Property, plant and equipment, at cost
|
|
465,358
|
|
|
462,840
|
|
||
Total assets
|
|
1,057,410
|
|
|
1,012,990
|
|
||
DI
|
|
|
|
|
||||
Customer revenues
|
|
298,571
|
|
|
308,193
|
|
||
Intersegment revenues
|
|
18,775
|
|
|
15,266
|
|
||
Operating loss
|
|
(653
|
)
|
|
(7,283
|
)
|
||
Capital expenditures
|
|
7,012
|
|
|
5,123
|
|
||
Depreciation
|
|
6,387
|
|
|
5,224
|
|
||
Property, plant and equipment, at cost
|
|
187,337
|
|
|
193,471
|
|
||
Total assets
|
|
1,573,982
|
|
|
1,518,547
|
|
||
TOTAL
|
|
|
|
|
||||
Customer revenues
|
|
698,491
|
|
|
614,157
|
|
||
Intersegment revenues
|
|
32,382
|
|
|
34,892
|
|
||
Operating profit
|
|
54,644
|
|
|
8,869
|
|
||
Capital expenditures
|
|
12,297
|
|
|
10,902
|
|
||
Depreciation
|
|
13,282
|
|
|
11,983
|
|
||
Property, plant and equipment, at cost
|
|
652,695
|
|
|
656,311
|
|
||
Total assets
|
|
2,631,392
|
|
|
2,531,537
|
|
|
|
2012
|
|
2011
|
||||
Diebold North America
|
|
$
|
399,920
|
|
|
$
|
305,964
|
|
Diebold International:
|
|
|
|
|
||||
Latin America including Brazil
|
|
137,668
|
|
|
152,888
|
|
||
Asia Pacific
|
|
96,200
|
|
|
83,889
|
|
||
Europe, Middle East and Africa
|
|
64,703
|
|
|
71,416
|
|
||
Total Diebold International
|
|
298,571
|
|
|
308,193
|
|
||
Total customer revenues
|
|
$
|
698,491
|
|
|
$
|
614,157
|
|
|
|
2012
|
|
2011
|
||||
Financial self-service:
|
|
|
|
|
||||
Services
|
|
$
|
299,935
|
|
|
$
|
264,456
|
|
Products
|
|
261,067
|
|
|
198,640
|
|
||
Total financial self-service
|
|
561,002
|
|
|
463,096
|
|
||
Security
|
|
|
|
|
||||
Services
|
|
96,840
|
|
|
99,918
|
|
||
Products
|
|
38,033
|
|
|
43,413
|
|
||
Total security
|
|
134,873
|
|
|
143,331
|
|
||
Total financial self-service & security
|
|
695,875
|
|
|
606,427
|
|
||
Election and lottery systems
|
|
2,616
|
|
|
7,730
|
|
||
Total customer revenues
|
|
$
|
698,491
|
|
|
$
|
614,157
|
|
•
|
A strategy that leverages its leadership in software-led services, attuned with the needs of the Company's core global markets for financial self-service (FSS) and security solutions.
|
•
|
The financial capacity to implement that strategy and fund the investments necessary to drive growth, while preserving the ability to return value to shareholders in the form of reliable, growing dividends and, as appropriate, share repurchases.
|
•
|
A disciplined risk assessment process, focused on proactively identifying and mitigating potential risks to the Company's continued success.
|
•
|
demand for new service offerings, including integrated services and outsourcing;
|
•
|
demand for security products and services for the financial sectors;
|
•
|
timing of self-service equipment upgrades and/or replacement cycles, including deposit automation in mature markets such as the United States; and
|
•
|
high levels of deployment growth for new self-service products in emerging markets, such as Asia Pacific.
|
|
|
Three Months Ended
|
||||||||||||
|
|
March 31,
|
||||||||||||
|
|
2012
|
|
2011
|
||||||||||
|
|
Dollars
|
|
% of
Net sales
|
|
Dollars
|
|
% of
Net sales
|
||||||
Net sales
|
|
$
|
698,491
|
|
|
100.0
|
|
|
$
|
614,157
|
|
|
100.0
|
|
Gross profit
|
|
193,240
|
|
|
27.7
|
|
|
149,404
|
|
|
24.3
|
|
||
Operating expenses
|
|
138,596
|
|
|
19.8
|
|
|
140,535
|
|
|
22.9
|
|
||
Operating profit
|
|
54,644
|
|
|
7.8
|
|
|
8,869
|
|
|
1.4
|
|
||
Income from continuing operations
|
|
45,965
|
|
|
6.6
|
|
|
4,146
|
|
|
0.7
|
|
||
Loss from discontinued operations, net of tax
|
|
—
|
|
|
—
|
|
|
(11
|
)
|
|
—
|
|
||
Net income attributable to noncontrolling interests
|
|
802
|
|
|
0.1
|
|
|
1,634
|
|
|
0.3
|
|
||
Net income attributable to Diebold, Incorporated
|
|
45,163
|
|
|
6.5
|
|
|
2,501
|
|
|
0.4
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
||||||
Net sales
|
|
$
|
698,491
|
|
|
$
|
614,157
|
|
|
$
|
84,334
|
|
|
13.7
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
||||||
Gross profit – services
|
|
$
|
111,469
|
|
|
$
|
88,484
|
|
|
$
|
22,985
|
|
|
26.0
|
Gross profit – products
|
|
81,771
|
|
|
60,920
|
|
|
20,851
|
|
|
34.2
|
|||
Total gross profit
|
|
$
|
193,240
|
|
|
$
|
149,404
|
|
|
$
|
43,836
|
|
|
29.3
|
Gross margin – services
|
|
28.1
|
%
|
|
24.3
|
%
|
|
|
|
|
||||
Gross margin – products
|
|
27.1
|
%
|
|
24.4
|
%
|
|
|
|
|
||||
Total gross margin
|
|
27.7
|
%
|
|
24.3
|
%
|
|
|
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
|||||||
Selling and administrative expense
|
|
$
|
119,795
|
|
|
$
|
121,111
|
|
|
$
|
(1,316
|
)
|
|
(1.1
|
)
|
Research, development and engineering expense
|
|
18,801
|
|
|
19,424
|
|
|
(623
|
)
|
|
(3.2
|
)
|
|||
Total operating expenses
|
|
$
|
138,596
|
|
|
$
|
140,535
|
|
|
$
|
(1,939
|
)
|
|
(1.4
|
)
|
|
|
2012
|
|
2011
|
|
$ Change/
|
|
% Change
|
||||||
Operating profit
|
|
$
|
54,644
|
|
|
$
|
8,869
|
|
|
$
|
45,775
|
|
|
516.1
|
Operating profit margin
|
|
7.8
|
%
|
|
1.4
|
%
|
|
|
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
|||||||
Investment income
|
|
$
|
11,955
|
|
|
$
|
10,898
|
|
|
$
|
1,057
|
|
|
9.7
|
|
Interest expense
|
|
(7,608
|
)
|
|
(8,673
|
)
|
|
(1,065
|
)
|
|
(12.3
|
)
|
|||
Foreign exchange gain (loss), net
|
|
545
|
|
|
(1,046
|
)
|
|
1,591
|
|
|
N/M
|
|
|||
Miscellaneous, net
|
|
(90
|
)
|
|
23
|
|
|
(113
|
)
|
|
N/M
|
|
|||
Other income (expense)
|
|
$
|
4,802
|
|
|
$
|
1,202
|
|
|
$
|
3,600
|
|
|
299.5
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
||||||
Income from continuing operations
|
|
$
|
45,965
|
|
|
$
|
4,146
|
|
|
$
|
41,819
|
|
|
N/M
|
Percent of net sales
|
|
6.6
|
%
|
|
0.7
|
%
|
|
|
|
|
||||
Effective tax rate
|
|
22.7
|
%
|
|
58.8
|
%
|
|
|
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
|||||||
DNA
|
|
$
|
399,920
|
|
|
$
|
305,964
|
|
|
$
|
93,956
|
|
|
30.7
|
|
DI
|
|
298,571
|
|
|
308,193
|
|
|
(9,622
|
)
|
|
(3.1
|
)
|
|||
Total net sales
|
|
$
|
698,491
|
|
|
$
|
614,157
|
|
|
$
|
84,334
|
|
|
13.7
|
|
|
|
2012
|
|
2011
|
|
$ Change
|
|
% Change
|
||||||
DNA
|
|
$
|
55,297
|
|
|
$
|
16,152
|
|
|
$
|
39,145
|
|
|
242.4
|
DI
|
|
(653
|
)
|
|
(7,283
|
)
|
|
6,630
|
|
|
91.0
|
|||
Total operating profit
|
|
$
|
54,644
|
|
|
$
|
8,869
|
|
|
$
|
45,775
|
|
|
516.1
|
|
|
2012
|
|
2011
|
||||
Net cash flow (used in) provided by:
|
|
|
|
|
||||
Operating activities
|
|
$
|
(26,021
|
)
|
|
$
|
(90,151
|
)
|
Investing activities
|
|
(19,783
|
)
|
|
2,197
|
|
||
Financing activities
|
|
18,540
|
|
|
35,958
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
|
4,781
|
|
|
2,900
|
|
||
Net decrease in cash and cash equivalents
|
|
$
|
(22,483
|
)
|
|
$
|
(49,096
|
)
|
•
|
competitive pressures, including pricing pressures and technological developments;
|
•
|
changes in the Company's relationships with customers, suppliers, distributors and/or partners in its business ventures;
|
•
|
changes in political, economic or other factors such as currency exchange rates, inflation rates, recessionary or expansive trends, taxes and regulations and laws affecting the worldwide business in each of the Company's operations, including Brazil, where a significant portion of the Company's revenue is derived;
|
•
|
global economic conditions, including any additional deterioration and disruptions in the financial markets, including bankruptcies, restructurings or consolidations of financial institutions, which could reduce our customer base and/or
|
•
|
acceptance of the Company's product and technology introductions in the marketplace;
|
•
|
the Company’s ability to maintain effective internal controls;
|
•
|
changes in the Company’s intention to repatriate cash and cash equivalents and short-term investments residing in international tax jurisdictions could negatively impact foreign and domestic taxes;
|
•
|
unanticipated litigation, claims or assessments, as well as the impact of any current or pending lawsuits;
|
•
|
variations in consumer demand for financial self-service technologies, products and services;
|
•
|
potential security violations to the Company's information technology systems;
|
•
|
the investment performance of the Company’s pension plan assets, which could require the Company to increase its pension contributions, and significant changes in health care costs, including those that may result from government action;
|
•
|
the amount and timing of repurchases of the Company’s common shares, if any;
|
•
|
the outcome of the Company’s global FCPA review and any actions taken by government agencies in connection with the Company’s self disclosure, including the pending SEC investigation; and
|
•
|
the Company’s ability to achieve benefits from its cost-reduction initiatives and other strategic changes, including its restructuring actions.
|
Period
|
|
Total Number of
Shares
Purchased (1)
|
|
Average Price
Paid Per Share
|
|
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans (2)
|
|
Maximum Number
of Shares that
May Yet Be
Purchased Under
the Plans (2)
|
|||||
January
|
|
806
|
|
|
$
|
30.14
|
|
|
—
|
|
|
2,426,177
|
|
February
|
|
71,460
|
|
|
38.44
|
|
|
—
|
|
|
2,426,177
|
|
|
March
|
|
3,157
|
|
|
35.86
|
|
|
—
|
|
|
2,426,177
|
|
|
Total
|
|
75,423
|
|
|
38.24
|
|
|
—
|
|
|
|
(1)
|
All shares were surrendered or deemed surrendered to the Company in connection with the Company’s share-based compensation plans.
|
(2)
|
The total number of shares repurchased as part of the publicly announced share repurchase plan since its inception was
13,450,772
as of
March 31, 2012
. The plan was approved by the Board of Directors in 1997. The Company may purchase shares from time to time in open market purchases or privately negotiated transactions. The Company may make all or part of the purchases pursuant to accelerated share repurchases or Rule 10b5-1 plans. The plan has no expiration date. The following table provides a summary of Board of Directors approvals to repurchase the Company’s outstanding common shares:
|
|
Total Number of Shares
Approved for Repurchase
|
|
1997
|
2,000,000
|
|
2004
|
2,000,000
|
|
2005
|
6,000,000
|
|
2007
|
2,000,000
|
|
2011
|
1,876,949
|
|
2012
|
2,000,000
|
|
|
15,876,949
|
|
•
|
Severance of two times base salary and target bonus for the CEO, and one and one-half times salary and target bonus for the other named executive officers, as well as a pro-rata award bonus payment, to the extent such awards are ultimately earned based on the Company's performance;
|
•
|
Two years of continued participation in our employee health and welfare benefit plans for our CEO, and one and one-half years of continued participation for the other named executive officers (excluding perquisites and any qualified or non-qualified pension or 401(k) plans);
|
•
|
Lapse of the restrictions on outstanding restricted shares;
|
•
|
Vesting of all outstanding non-vested options, which shall remain exercisable for three months;
|
•
|
Pro-rata vesting of all outstanding RSUs and performance shares (to the extent such awards are earned); and
|
•
|
Professional outplacement services for up to two years.
|
3.1(i)
|
|
Amended and Restated Articles of Incorporation of Diebold, Incorporated – incorporated by reference to Exhibit 3.1(i) to Registrant’s Annual Report on Form 10-K for the year ended December 31, 1994 (Commission File No. 1-4879)
|
|
|
|
3.1(ii)
|
|
Amended and Restated Code of Regulations – incorporated by reference to Exhibit 3.1(ii) to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (Commission File No. 1-4879)
|
|
|
|
3.2
|
|
Certificate of Amendment by Shareholders to Amended Articles of Incorporation of Diebold, Incorporated – incorporated by reference to Exhibit 3.2 to Registrant’s Form 10-Q for the quarter ended March 31, 1996 (Commission File No. 1-4879)
|
|
|
|
3.3
|
|
Certificate of Amendment to Amended Articles of Incorporation of Diebold, Incorporated – incorporated by reference to Exhibit 3.3 to Registrant’s Form 10-K for the year ended December 31, 1998 (Commission File No. 1-4879)
|
|
|
|
10.31
|
|
Diebold, Incorporated Senior Leadership Severance Plan (For Tier I, Tier II, and Tier III Executives)
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
|
|
*101.INS
|
|
XBRL Instance Document
|
|
|
|
*101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
*101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
*101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
*101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
*101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
|
|
|
DIEBOLD, INCORPORATED
|
|
|
|
|
|
|
|
|
Date: April 30, 2012
|
|
By:
|
/s/ Thomas W. Swidarski
|
|
|
|
Thomas W. Swidarski
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
Date: April 30, 2012
|
|
By:
|
/s/ Bradley C. Richardson
|
|
|
|
Bradley C. Richardson
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
EXHIBIT NO.
|
|
DOCUMENT DESCRIPTION
|
|
|
|
10.31
|
|
Diebold, Incorporated Senior Leadership Severance Plan (For Tier I, Tier II, and Tier III Executives)
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
|
*101.INS
|
|
XBRL Instance Document
|
|
|
|
*101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
*101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
*101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
*101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
*101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
Article 1. Establishment and Term of the Plan
|
1
|
Article 2. Definitions
|
1
|
Article 3. Severance Benefits
|
4
|
Article 4. Confidentiality and Noncompetition
|
6
|
Article 5. Legal Fees and Notice
|
7
|
Article 6. Successors and Assignment
|
8
|
Article 7. Miscellaneous
|
8
|
Appendix
|
A-1
|
(a)
|
“Base Salary”
means the Executive’s annual rate of salary, whether or not deferred as of the Effective Date of Termination.
|
(b)
|
“Beneficiary”
means the persons or entities designated or deemed designated by the Executive pursuant to Section 7.5 herein.
|
(c)
|
“Board”
means the Board of Directors of the Company.
|
(d)
|
“Cause”
shall mean the Executive’s”
|
(i)
|
Willful failure to substantially perform his duties with the Company (other than any such failure resulting from the Executive’s Disability), after a written demand for substantial performance is delivered to the Executive that specifically identifies the manner in which the Company believes that the Executive has not substantially p
|
(ii)
|
Willful gross negligence in the performance of the Executive’s duties;
|
(iii)
|
Conviction of, or plea of guilty or nolo contendere, to any felony or a lesser crime or offense which, in the reasonable opinion of the Company, could adversely affect the business or reputation of the Company;
|
(iv)
|
Willful engagement in conduct that is demonstrably and materially injurious to the Company, monetarily or otherwise;
|
(v)
|
Willful violation of any provision of the Company’s code of conduct;
|
(vi)
|
Willful violation of any of the covenants contained in Article 4 of this Plan, as applicable;
|
(vii)
|
Act of dishonesty resulting in, or intended to result in, personal gain at the expense of the Company; or
|
(viii)
|
Engaging in any act that is intended to harm, or may be reasonably expected to harm, the reputation, business prospects, or operations of the Company.
|
(e)
|
“Code”
means the United States Internal Revenue Code of 1986, as amended, and any successors thereto.
|
(f)
|
“Committee”
means the Compensation Committee of the Board or any other committee appointed by the Board to perform the functions of the Compensation Committee.
|
(g)
|
“Company”
means Diebold, Incorporated, an Ohio corporation, or any successor thereto as provided in Article 6 herein.
|
(h)
|
“Disability”
shall have the same meaning ascribed to that word in the long-term disability plan in effect for senior executives of the Company and its Subsidiaries.
|
(i)
|
“Effective Date”
means the commencement date of this Plan as specified in Section 1.2 of this Plan.
|
(j)
|
“Effective Date of Termination”
means the date on which a Qualifying Termination occurs, as defined hereunder, which triggers the payment of Severance Benefits hereunder.
|
(k)
|
“Good Reason”
shall mean the occurrence of any one or more of the following without the Executive’s express written consent:
|
(iv)
|
Any other action or inaction by the Company that constitutes a material breach by the Company of the terms and conditions of this Plan.
|
(l)
|
“Notice of Termination”
shall mean a written notice that shall indicate the specific termination provision in this Plan relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated.
|
(m)
|
“Qualifying Termination”
means a termination of employment under the following circumstances:
|
(i)
|
An involuntary termination of the Executive’s employment by the Company for reasons other than Cause pursuant to a Notice of Termination delivered to the Executive by the Company; or
|
(ii)
|
A voluntary termination by the Executive for Good Reason pursuant to a Notice of Termination delivered to the Company by the Executive.
|
(n)
|
“Severance Benefits”
means the payment of severance compensation as provided in Article 3 herein.
|
(a)
|
Severance Benefits.
The Executive shall be entitled to receive from the Company Severance Benefits, as described in Section 3.2 herein, if a Qualifying Termination of the Executive’s employment has occurred.
|
(b)
|
No Severance Benefits.
The Executive shall not be entitled to receive Severance Benefits if the Executive’s employment with the Company ends for reasons other than a Qualifying Termination.
|
(c)
|
General Release and Acknowledgement of Restrictive Covenants.
As a condition to receiving Severance Benefits under Section 3.2 herein, no later than sixty (60) days after the date of the Executive’s Qualifying Termination, (i) the Executive shall be obligated to execute a general release of claims in favor of the Company, its current and former affiliates and stockholders, and the current and former directors, officers, employees, and agents of the Company in a form acceptable to the Company, (ii) the Executive must execute a notice acknowledging the restrictive covenants in Article 4, and (iii) the Executive’s general release shall have become irrevocable.
|
(a)
|
A lump‑sum amount, paid sixty (60) calendar days
following the Effective Date of Termination, equal to the Executive’s unpaid Base Salary, accrued vacation pay, unreimbursed business expenses, and all other items earned by and owed to the Executive through and including the Effective Date of Termination; provided that if the sixty (60) day period begins in an Executive’s taxable year and ends in the Executive’s subsequent taxable year, the payment will be made in the subsequent taxable year.
|
(b)
|
A lump‑sum amount, paid within the sixty (60) calendar days following the Effective Date of Termination, equal to: (i) two (2) for Tier I Executives, (ii) one and one‑half (1.5) for Tier II Executives, and (iii) one (1) for Tier III Executives, multiplied by the sum of the following: (A) the Executive’s Base Salary, and (B) the Executive’s annual target bonus opportunity in the year of termination; provided that if the sixty (60) day period begins in an Executive’s taxable year and ends in the Executive’s subsequent taxable year, the payment will be made in the subsequent taxable year.
|
(c)
|
A lump‑sum amount, if any, paid within two and one‑half (2 ½) months after the end of the calendar year that includes the Effective Date of Termination, equal to the actual bonus that would have been payable to the Executive for the calendar year that includes the Effective Date of Termination based on actual performance if the Executive had remained employed through the end of such calendar year; provided however, that such amount shall be adjusted on a pro rata basis based on the number of days the Executive was actually employed during the bonus plan year in which the Qualifying Termination occurs.
|
(d)
|
Continuation of the Executive’s medical, dental, vision, and Company-paid basic life insurance coverage for: (i) two (2) years for Tier I Executives, or (ii) one and one-half (1.5) years for Tier II, and one (1) year for Tier III Executives. These benefits shall be provided by the Company to the Executive beginning immediately upon the Effective Date of Termination. Such benefits shall be provided to the Executive at the same coverage level and cost to the Executive as in effect immediately prior to the Executive’s Effective Date of Termination. Notwithstanding the foregoing, if the Executive is a “specified employee” within the meaning of Section 409A of the Code, then the benefits provided under this Section 3.2(d) which the Company determines constitute the payment of deferred compensation (within the meaning of Section 409A of the Code) shall be provided at the Executive’s sole cost during the six (6) month period immediately after the Effective Date of Termination, and as soon as administratively practicable following the expiration of such six (6) month period, the Company shall reimburse the Executive for the portion of such costs payable by the Company hereunder.
|
(e)
|
Treatment of outstanding long‑term incentives shall be in accordance with Section 3.3 herein.
|
(f)
|
The Company will assist the Executive in finding other employment opportunities by providing to him, at the Company’s limited expense, professional outplacement services through the provider of the Company’s choice. Such outplacement services shall terminate when the Executive finds other employment. However, in no event shall such outplacement services continue for more than two (2) years following the Effective Date of Termination.
|
(g)
|
Notwithstanding anything in this Plan to the contrary, if the Executive constitutes a “specified employee” as defined and applied in Section 409A of the Code, as of the Effective Date of Termination, to the extent payments made under Sections 3.2(a), (b), or (c) constitute deferred compensation (after taking into account any applicable exemptions from Section 409A of the Code), and to the extent required by Section 409A of the Code, payments may not commence to be paid to Executive until the earlier of: (i) the first day following the six (6) month anniversary of the Executive’s Effective Date of Termination, or (ii) the Executive’s date of death; provided, however, that any payments delayed during this six (6) month period shall be paid in a lump sum as soon as administratively practicable following the six (6) month
|
(a)
|
All outstanding and unvested stock options and stock appreciation rights (“SARs”) shall immediately vest and shall remain exercisable for a period of three (3) months from the Effective Date of Termination or the last day of the option term, whichever occurs first. Additionally, from time to time, the Company may declare "blackout" periods with respect to designated employees of the Company during which such employees are prohibited from engaging in certain transactions in Company securities. In the event that the scheduled expiration date of this option and SAR shall fall within a blackout period that has been declared by the Company and that applies to an option/SAR holder, then the expiration date shall automatically, and without further notice to option/SAR holder, be extended until such time as fifteen (15) consecutive business days have elapsed after the scheduled expiration date without interruption by any blackout period that applied to the option/SAR holder.
|
(b)
|
All restrictions on unvested shares of restricted stock and unvested restricted stock units shall immediately lapse, with such shares and units becoming nonforfeitable on a pro rata basis, as determined under this subparagraph (b). The pro rata award shall equal the product of (x) and (y) where (x) is the number of restricted stock shares or units subject to the award, and (y) is a fraction, the numerator of which is the number of calendar months that the Executive was employed by the Company during the restriction period (with any partial months counting as a full month for this purpose) and the denominator of which is the number of months in the restriction period.
|
(c)
|
Unearned performance shares and performance units shall be paid out on a pro rata basis, as determined under this subparagraph (c). The pro rata award shall equal the product of (x) and (y) where (x) is the award the Executive would have earned based on actual performance measured as of the end of the respective performance period and (y) is a fraction, the numerator of which is the number of calendar months that the Executive was employed by the Company during the performance period (with any partial month counting as a full month for this purpose) and the denominator of which is the number of months in the performance period.
|
(a)
|
Noncompetition.
During the Executive’s Employment and for a period of: (i) two (2) years for Tier I Executives, (ii) one and one-half (1 ½) years for Tier II Executives, and (iii) one (1) year for Tier III Executives after the Effective Date of Termination, the Executive shall not: (A) directly or indirectly act in concert or conspire with any person employed by the Company in order to engage in or prepare to engage in or to have a financial or other interest in any business or any activity that he knows (or reasonably should have known) to be directly competitive with the business of the Company as then being carried on; or (B) serve as an employee, agent, partner, shareholder, director, or consultant for, or in any other capacity participate, engage, or have a financial or other interest in any business or any activity that he knows (or reasonably should have known) to be directly competitive with the business of the Company as then being carried on (provided, however, that notwithstanding anything to the contrary contained in this Plan, the Executive may own up to two percent (2%) of the outstanding shares of the capital stock of a company whose securities are registered under Section 12 of the Securities Exchange Act of 1934).
|
(b)
|
Confidentiality.
The Company has advised the Executive and the Executive acknowledges that it is the policy of the Company to maintain as secret and confidential all Protected Information (as defined below), and that Protected Information has been and will be developed at substantial cost and effort to the Company. The Executive shall not at any time, directly or indirectly, divulge, furnish, or make accessible to any person, firm, corporation, association, or other entity (otherwise than as may be required in the regular course of the Executive’s employment), nor use in any manner, either during the Executive’s employment or after termination for any reason, any Protected Information, or cause any such Protected Information of the Company to enter the public domain.
|
(c)
|
Nonsolicitation.
During the Executive’s employment and for a period of: (i) three (3) years for Tier I Executives, (ii) two and one-half (2 ½) years for Tier II Executives, and (iii) two (2) year for Tier III Executives after the Effective Date of Termination, the Executive shall not: (A) employ or retain or solicit for employment or arrange to have any other person, firm, or other entity employ or retain or solicit for employment or otherwise participate in the employment or retention of any person who is an employee or consultant of the Company; or (B) solicit suppliers or customers of the Company or induce any such person to terminate his, her, or its relationship with the Company.
|
(d)
|
Cooperation.
Executive agrees to cooperate with the Company and its attorneys in connection with any and all lawsuits, claims, investigations, or similar proceedings that have been or could be asserted at any time arising out of or related in any way to Executive’s employment by the Company or any of its subsidiaries.
|
(e)
|
Nondisparagement.
At all times, the Executive agrees not to disparage the Company or otherwise make comments harmful to the Company’s reputation.
|
(f)
|
Severability.
If any provision of Article 4 is held to be unenforceable, then this Agreement will be deemed amended to the extent necessary to render the otherwise unenforceable provision, and the rest of Article 4, valid and enforceable. If a court declines to amend the provisions of Article 4 as provided herein, the invalidity or unenforceability of any provision in Article 4 shall not affect the validity or enforceability of the remaining provisions in Article 4, which shall be enforced as if the offending provision had not been included in this Plan.
|
1)
|
I have reviewed this quarterly report on Form 10-Q of Diebold, Incorporated;
|
2)
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3)
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4)
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5)
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: April 30, 2012
|
|
|
/s/ Thomas W. Swidarski
|
|
|
|
Thomas W. Swidarski
|
|
|
|
President and Cheif Executive Officer
(Principal Executive Officer)
|
1)
|
I have reviewed this quarterly report on Form 10-Q of Diebold, Incorporated;
|
2)
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3)
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4)
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5)
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: April 30, 2012
|
|
|
/s/ Bradley C. Richardson
|
|
|
|
Bradley C. Richardson
|
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
1
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
April 30, 2012
|
|
|
/s/ Thomas W. Swidarski
|
|
|
|
Thomas W. Swidarski
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
1
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
April 30, 2012
|
|
|
/s/ Bradley C. Richardson
|
|
|
|
Bradley C. Richardson
|
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|